These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


177 related items for PubMed ID: 11349265

  • 1. The use of hepatitis C viral RNA levels in liver tissue to distinguish rejection from recurrent hepatitis C.
    Gottschlich MJ, Aardema KL, Burd EM, Nakhleh RE, Brown KA, Abouljoud MS, Hirst K, Moonka DK.
    Liver Transpl; 2001 May; 7(5):436-41. PubMed ID: 11349265
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Use of OKT3 is associated with early and severe recurrence of hepatitis C after liver transplantation.
    Rosen HR, Shackleton CR, Higa L, Gralnek IM, Farmer DA, McDiarmid SV, Holt C, Lewin KJ, Busuttil RW, Martin P.
    Am J Gastroenterol; 1997 Sep; 92(9):1453-7. PubMed ID: 9317061
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. IgM anti-hepatitis C virus core antibodies as marker of recurrent hepatitis C after liver transplantation.
    Negro F, Giostra E, Rubbia-Brandt L, Mentha G, Colucci G, Morel P, Quadri R, Perrin L, Hadengue A.
    J Med Virol; 1998 Nov; 56(3):224-9. PubMed ID: 9783689
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Immunohistochemical staining of liver grafts with a monoclonal antibody against HCV-Envelope 2 for recurrent hepatitis C after living donor liver transplantation.
    Sadamori H, Yagi T, Iwagaki H, Matsuda H, Shinoura S, Umeda Y, Ohara N, Yanai H, Ogino T, Tanaka N.
    J Gastroenterol Hepatol; 2009 Apr; 24(4):574-80. PubMed ID: 19368635
    [Abstract] [Full Text] [Related]

  • 8. Evolution of hepatitis C virus in liver allografts.
    Demetris AJ.
    Liver Transpl; 2009 Nov; 15 Suppl 2():S35-41. PubMed ID: 19876940
    [Abstract] [Full Text] [Related]

  • 9. Intrahepatic cytokine profiles associated with posttransplantation hepatitis C virus-related liver injury.
    Zekry A, Bishop GA, Bowen DG, Gleeson MM, Guney S, Painter DM, McCaughan GW.
    Liver Transpl; 2002 Mar; 8(3):292-301. PubMed ID: 11910576
    [Abstract] [Full Text] [Related]

  • 10. ELISA-based detection of C4d after liver transplantation--a helpful tool for differential diagnosis between acute rejection and HCV-recurrence?
    Schmeding M, Kienlein S, Röcken C, Neuhaus R, Neuhaus P, Heidenhain C, Neumann UP.
    Transpl Immunol; 2010 Aug; 23(4):156-60. PubMed ID: 20558292
    [Abstract] [Full Text] [Related]

  • 11. Levels of hepatitis C virus RNA and liver histology in chronic type C hepatitis.
    Gordon SC, Kodali VP, Silverman AL, Dmuchowski CF, Urdea MS, Chan CS, Wilber JC.
    Am J Gastroenterol; 1994 Sep; 89(9):1458-61. PubMed ID: 8079919
    [Abstract] [Full Text] [Related]

  • 12. High levels of hepatitis C virus RNA in native livers correlate with the development of cholestatic hepatitis in liver allografts and a poor outcome.
    Deshpande V, Burd E, Aardema KL, Ma CK, Moonka DK, Brown KA, Abouljoud MS, Nakhleh RE.
    Liver Transpl; 2001 Feb; 7(2):118-24. PubMed ID: 11172395
    [Abstract] [Full Text] [Related]

  • 13. Survival and hepatitis C virus recurrence after liver transplantation in HIV- and hepatitis C virus-coinfected patients: experience in a single center.
    Testillano M, Fernandez JR, Suarez MJ, Gastaca M, Bustamante J, Pijoan JI, Montejo M, Valdivieso A, Ruiz P, Gonzalez J, Ortiz de Urbina J.
    Transplant Proc; 2009 Apr; 41(3):1041-3. PubMed ID: 19376421
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of liver histology, ALT elevation, and HCV RNA titer in patients with chronic hepatitis C.
    McCormick SE, Goodman ZD, Maydonovitch CL, Sjogren MH.
    Am J Gastroenterol; 1996 Aug; 91(8):1516-22. PubMed ID: 8759653
    [Abstract] [Full Text] [Related]

  • 15. The influence of viral genotypes and rejection episodes on the recurrence of hepatitis C after liver transplantation.
    Sugo H, Balderson GA, Crawford DH, Fawcett J, Lynch SV, Strong RW, Futagawa S.
    Surg Today; 2003 Aug; 33(6):421-5. PubMed ID: 12768367
    [Abstract] [Full Text] [Related]

  • 16. Cytokine profile of liver- and blood-derived nonspecific T cells after liver transplantation: T helper cells type 1/0 lymphokines dominate in recurrent hepatitis C virus infection and rejection.
    Schirren CA, Jung M, Worzfeld T, Mamin M, Baretton GB, Gruener NH, Gerlach JT, Diepolder HM, Zachoval R, Pape GR.
    Liver Transpl; 2000 Mar; 6(2):222-8. PubMed ID: 10719024
    [Abstract] [Full Text] [Related]

  • 17. Differential allograft gene expression in acute cellular rejection and recurrence of hepatitis C after liver transplantation.
    Sreekumar R, Rasmussen DL, Wiesner RH, Charlton MR.
    Liver Transpl; 2002 Sep; 8(9):814-21. PubMed ID: 12200784
    [Abstract] [Full Text] [Related]

  • 18. Characterization of CD4, CD8, CD56 positive lymphocytes and C4d deposits to distinguish acute cellular rejection from recurrent hepatitis C in post-liver transplant biopsies.
    Jain A, Ryan C, Mohanka R, Orloff M, Abt P, Romano J, Bryan L, Batzold P, Mantry P, Bozorgzadeh A.
    Clin Transplant; 2006 Sep; 20(5):624-33. PubMed ID: 16968489
    [Abstract] [Full Text] [Related]

  • 19. c-Kit-positive mast cells in portal tracts cannot be used to distinguish acute cellular rejection from recurrent hepatitis C infection in liver allografts.
    Doria C, di Francesco F, Marino IR, Ramirez CB, Frank A, Iaria M, Galati SA, Farber JL.
    Transplant Proc; 2006 Dec; 38(10):3597-600. PubMed ID: 17175342
    [Abstract] [Full Text] [Related]

  • 20. Impact of tacrolimus versus cyclosporine in hepatitis C virus-infected liver transplant recipients on recurrent hepatitis: a prospective, randomized trial.
    Martin P, Busuttil RW, Goldstein RM, Crippin JS, Klintmalm GB, Fitzsimmons WE, Uleman C.
    Liver Transpl; 2004 Oct; 10(10):1258-62. PubMed ID: 15376310
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.